Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Leukemia & Lymphoma|June 25, 1998
Therapy-related chronic myeloid leukemia: an epidemiological, clinical and pathogenetic appraisalR C AguiarHaematologica|January 1, 1993
Granulocytic sarcoma of the ovary in a nonleukemic patientR C Aguiar, D H Pozzi, D A ChamoneLeukemia|February 1, 1997
The commonly deleted region at 9p21-22 in lymphoblastic leukemias spans at least 400 kb and includes p16 but not p15 or the IFN gene clusterR C Aguiar, H Sill, J M Goldman, et al.Methods in Molecular Biology (Clifton, N.J.)|March 4, 2020
HLApers: HLA Typing and Quantification of Expression with Personalized IndexVitor R C Aguiar, Cibele Masotti, Anamaria A Camargo, et al.Blood|May 23, 1998
A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemiaM Carapeti, R C Aguiar, J M Goldman, et al.The Journal of Clinical Endocrinology and Metabolism|June 9, 2001
Analysis of the SDHD gene, the susceptibility gene for familial paraganglioma syndrome (PGL1), in pheochromocytomasR C Aguiar, G Cox, S L Pomeroy, et al.Acta Haematologica|January 1, 1994
Secondary chronic myelogenous leukemia: a diverse pathogenesis?R C Aguiar, B Beitler, P E Dorlhiac-Llacer, et al.Plos Genetics|April 23, 2019
Expression estimation and eQTL mapping for HLA genes with a personalized pipelineVitor R C Aguiar, Jônatas César, Olivier Delaneau, et al.British Journal of Cancer|September 23, 1998
Aberrant transcripts of the FHIT gene are expressed in normal and leukaemic haemopoietic cellsM Carapeti, R C Aguiar, H Sill, et al.Cancer Genetics and Cytogenetics|August 25, 1999
Consistent fusion of MOZ and TIF2 in AML with inv(8)(p11q13)M Carapeti, R C Aguiar, A E Watmore, et al.Pageof 5